β-glucans and cholesterol (Review)

Area of Science:

• Biochemistry
• Nutrition Science
• Pharmacology

Background:

• Hypercholesterolemia is a major risk factor for cardiovascular disease, often co-occurring with metabolic syndrome, hypertension, and diabetes.
• Current treatments for cardiovascular disease and dyslipidemia can cause significant side effects, driving the search for novel therapeutic strategies.
• Beta-glucans are naturally occurring polysaccharides with unique structures that allow interaction with both immune receptors and digestive components.

Purpose of the Study:

• To review the existing evidence on the cholesterol-lowering effects of beta-glucans.
• To evaluate the potential of beta-glucans as a therapeutic option for managing dyslipidemia.
• To highlight the safety profile of beta-glucans as natural compounds.

Main Methods:

• This review synthesizes findings from studies investigating the impact of beta-glucans on lipid profiles.
• Evidence from research on both soluble and insoluble forms of beta-glucans is considered.
• The mechanism of action in the digestive tract, involving interaction with lipids and bile salts, is examined.

Main Results:

• Beta-glucans, acting as dietary fibers, demonstrate an ability to reduce cholesterol levels.
• Both soluble and insoluble beta-glucans interact with lipids and bile salts in the gastrointestinal tract.
• These interactions contribute to a reduction in overall cholesterol levels.

Conclusions:

• Beta-glucans show significant promise as a natural and safe therapeutic agent for hypercholesterolemia and dyslipidemia.
• Their mechanism of action in the digestive tract supports their efficacy in cholesterol management.
• Further development of beta-glucans could offer a valuable alternative or adjunct to existing therapies with fewer side effects.